Galderma Group AG (FRA:PY30) ROE % Adjusted to Book Value : 0.00% (As of Jun. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Galderma Group AG ROE % Adjusted to Book Value?

Galderma Group AG's ROE % for the quarter that ended in Jun. 2024 was 1.23%. Galderma Group AG's PB Ratio for the quarter that ended in Jun. 2024 was N/A. Galderma Group AG's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2024 was N/A.

Galderma Group AG ROE % Adjusted to Book Value Historical Data

The historical data trend for Galderma Group AG's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Galderma Group AG ROE % Adjusted to Book Value Chart

Galderma Group AG Annual Data

Trend

ROE % Adjusted to Book Value

Galderma Group AG Semi-Annual Data
	Jun23	Jun24
ROE % Adjusted to Book Value	-	-

Competitive Comparison of Galderma Group AG's ROE % Adjusted to Book Value

For the Drug Manufacturers - Specialty & Generic subindustry, Galderma Group AG's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Galderma Group AG's ROE % Adjusted to Book Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Galderma Group AG's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Galderma Group AG's ROE % Adjusted to Book Value falls into.

Galderma Group AG ROE % Adjusted to Book Value Calculation

Galderma Group AG's ROE % Adjusted to Book Value for the fiscal year that ended in . 20 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	0.00%	/	N/A
	=	N/A

Galderma Group AG's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	1.23%	/	N/A
	=	N/A

Galderma Group AG ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Galderma Group AG's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Galderma Group AG Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Galderma Group AG (FRA:PY30) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

GALDY:USA GDERF:USA GALDz:UK GALD:Switzerland

Address

Zahlerweg 10, Zug, CHE, 6300

Website

https://www.galderma.com

Galderma was formed in 1981 as a joint venture between Nestle and L'Oreal. It subsequently became a subsidiary of Nestle, called Nestle Skin Health, before being carved out and launched as a standalone company in 2019, acquired by a consortium led by Sweden-based EQT fund. The company went public in March 2024 and is listed on the SIX Swiss exchange. Galderma's science-based portfolio spans multiple dermatology categories, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. It derives around 45% of net sales from the US and employs around 6,600 people.

Galderma Group AG Headlines

No Headlines